N-PX: Filer Information

Filer CIK

0000872589

Filer CCC

********

Date of Report

06/30/2026

Are you a Registered Management Investment Company or an Institutional Manager?

Institutional Manager

Is this a LIVE or TEST Filing?

LIVE

TEST

Is this an electronic copy of an official filing submitted in paper format?

Submission Contact Information

Name

Phone Number

E-mail Address

Notification Information

Notify via Filing Website only?

N-PX: Cover Page

Name and address of reporting person:

Name of reporting person (For registered management investment companies, provide exact name of registrant as specified in charter)

REGENERON PHARMACEUTICALS, INC.

Street 1

777 Old Saw Mill River Road

Street 2

City

Tarrytown

State/Country

NEW YORK

Zip code and zip code extension or foreign postal code

10591

Telephone number of reporting person, including area code:

914-847-7000

Name and address of agent for service:

Name of agent for service

Street 1

Street 2

City

State/Country

Zip code and zip code extension or foreign postal code

Reporting Period:

Report for the year ended June 30, 2026

SEC Investment Company Act or Form 13F File Number:

028-24826

CRD Number (if any):

Other SEC File Number (if any):

Legal Entity Identifier (if any):

Report Type (check only one):

Registered Management Investment Company.

Fund Voting Report (Check here if the registered management investment company held one or more securities it was entitled to vote.)

Fund Notice Report (Check here if the registered management investment company did not hold any securities it was entitled to vote.)

Institutional Manager.

Institutional Manager Voting Report (Check here if all proxy votes of this reporting manager are reported in this report.)

Institutional Manager Notice Report (Check here if no proxy votes are reported in this report and complete the notice report filing explanation section below)

Institutional Manager Combination Report (Check here if a portion of the proxy votes for this reporting manager are reported in this report and a portion are reported by other reporting person(s).)

Do you wish to provide explanatory information pursuant to Special Instruction B.4?:

Yes

Additional information:

N-PX: Summary - Included Managers

Number of Included Institutional Managers:

Included Institutional Managers:

NONE

N-PX: Signature Block

Reporting Person:

REGENERON PHARMACEUTICALS, INC.

By (Signature):

/s/ Leonard Brooks

By (Printed Signature):

/s/ Leonard Brooks

By (Title):

Senior Vice President, Treasurer

Date:

08/20/2026

FORM N-PX PROXY VOTING RECORD

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5	COLUMN 6	COLUMN 7	COLUMN 8	COLUMN 9	COLUMN 10	COLUMN 11	COLUMN 12			COLUMN 13	COLUMN 14	COLUMN 15
NAME OF ISSUER	CUSIP	ISIN	FIGI	MEETING DATE	VOTE DESCRIPTION	VOTE CATEGORY	DESCRIPTION OF OTHER CATEGORY	VOTE SOURCE	SHARES VOTED	SHARES ON LOAN	DETAILS OF VOTE			MANAGER NUMBER	SERIES ID	OTHER INFO
NAME OF ISSUER	CUSIP	ISIN	FIGI	MEETING DATE	VOTE DESCRIPTION	VOTE CATEGORY	DESCRIPTION OF OTHER CATEGORY	VOTE SOURCE	SHARES VOTED	SHARES ON LOAN	HOW VOTED	SHARES VOTED	FOR OR AGAINST MANAGEMENT	MANAGER NUMBER	SERIES ID	OTHER INFO
Adicet Bio, Inc.	007002207	-	-	06/17/2026	To ratify, on a non-binding advisory basis, the compensation of our named executive officers.	SECTION 14A SAY-ON-PAY VOTES	-	-	60511	0	FOR	60511	FOR		-	-
Intellia Therapeutics, Inc.	45826J105	-	-	06/09/2026	Approval, on a non-binding advisory basis, of the compensation of our named executive officers.	SECTION 14A SAY-ON-PAY VOTES	-	-	3702995	0	FOR	3702995	FOR		-	-

[Repeat as Necessary]